Orthofix pivots to spine, extremities (MassDevice)
Orthofix (NSDQ:OFIX) said yesterday that it’s planning a pivot to the spine and extremities market beginning next year, folding its biostim and biologics businesses back into the spine segment five years after it split them out in the first place.
In July 2013 Lewisville, Texas-based Orthofix split the spine segment into biostim and spine fixation divisions, promoting Brad Niemann from commercial operations SVP to lead the biostim biz. Later that month the company restated its financial results covering more than two years, after discovering...